Eosinophilic Asthma Market Report 2026
Download Free Sample Buy Now
Eosinophilic Asthma Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Eosinophilic Asthma Market Report 2026

Global Outlook – By Disease (Severe Eoisnophilic Asthma, Mild To Moderate Eosinophilic Asthma), By Treatment (Biologics, Bronchodilators, Corticosteroids, Immunomodulators, Other Treatments), By End User (Hospitals, Clinics, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Eosinophilic Asthma Market Overview

• Eosinophilic Asthma market size has reached to $3.16 billion in 2025

• Expected to grow to $6.92 billion in 2030 at a compound annual growth rate (CAGR) of 16.9%

• Growth Driver: Impact Of Rising Smoking Habits On The Growth Of The Market

• Market Trend: Advancements In Targeted Therapies For Severe Asthma Management

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Eosinophilic Asthma Market?

Eosinophilic asthma is a form of asthma where high eosinophil counts, a specific white blood cell type, cause airway inflammation. This condition results in severe symptoms such as breathing issues and recurring flare-ups, with limited effectiveness from standard treatments such as inhaled steroids.

The main diseases types in the eosinophilic asthma are severe eosinophilic asthma and mild to moderate eosinophilic asthma. Severe eosinophilic asthma is a severe variant of asthma marked by elevated levels of eosinophils, a type of white blood cell that plays a role in airway inflammation. Treatment options include biologics, bronchodilators, corticosteroids, immunomodulators, and other therapies. These treatments are used in hospitals, clinics, and other healthcare settings.

Eosinophilic Asthma Market Global Report 2026 Market Report bar graph

What Is The Eosinophilic Asthma Market Size and Share 2026?

The eosinophilic asthma market size has grown rapidly in recent years. It will grow from $3.16 billion in 2025 to $3.71 billion in 2026 at a compound annual growth rate (CAGR) of 17.4%. The growth in the historic period can be attributed to poor response to inhaled steroids, asthma prevalence growth, eosinophil biomarker identification, hospital asthma admissions, chronic respiratory disease burden.

What Is The Eosinophilic Asthma Market Growth Forecast?

The eosinophilic asthma market size is expected to see rapid growth in the next few years. It will grow to $6.92 billion in 2030 at a compound annual growth rate (CAGR) of 16.9%. The growth in the forecast period can be attributed to precision asthma treatment growth, biologic drug pipeline expansion, biomarker-based diagnosis, personalized respiratory care, specialty clinic expansion. Major trends in the forecast period include growing adoption of biologic therapies, increased focus on severe asthma phenotypes, rising demand for targeted immunotherapy, expansion of specialized respiratory clinics, emphasis on reducing exacerbation rates.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Eosinophilic Asthma Market Segmentation

1) By Disease: Severe Eoisnophilic Asthma, Mild To Moderate Eosinophilic Asthma

2) By Treatment: Biologics, Bronchodilators, Corticosteroids, Immunomodulators, Other Treatments

3) By End User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Severe Eosinophilic Asthma: Refractory Eosinophilic Asthma, Late-Onset Eosinophilic Asthma

2) By Mild To Moderate Eosinophilic Asthma: Early-Onset Eosinophilic Asthma, Intermittent Eosinophilic Asthma

What Is The Driver Of The Eosinophilic Asthma Market?

The rising smoking habits are expected to propel the growth of the eosinophilic asthma market going forward. Smoking habits refer to the regular behaviors or patterns of using tobacco products, such as the frequency, context, and duration of smoking, often influenced by psychological, social, and environmental factors. The rising smoking habits are due to factors such as increased stress levels, targeted marketing by tobacco companies, lack of awareness about health risks, and social acceptance of smoking in certain cultures. Eosinophilic asthma treatment helps reduce airway inflammation and improve lung function, which can encourage smoking cessation by alleviating the respiratory issues that often drive patients to continue smoking. For instance, in November 2025, according to the Office for National Statistics, a UK-based government agency, the percentage of women who reported using e-cigarettes in Great Britain increased from 8.5% in 2023 to 10.0% in 2024. Further, daily e-cigarette use was highest among people aged 25 to 34 years and 35 to 49 years in Great Britain (9.3% and 9.5%, respectively) and has increased among both age groups from 2023. Therefore, the rising smoking rates is driving the eosinophilic asthma industry.

Key Players In The Global Eosinophilic Asthma Market

Major companies operating in the eosinophilic asthma market are Roche Holding AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, GSK plc, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Regeneron Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A., Pfizer Inc., Merck & Co. Inc., Johnson & Johnson, Bayer AG, Eli Lilly and Company, AbbVie Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Cipla Ltd., Sumitomo Dainippon Pharma Co. Ltd., Kyowa Kirin Co. Ltd., UCB S.A., 4D Pharma plc, MorphoSys AG, Avalo Therapeutics Inc.

Global Eosinophilic Asthma Market Trends and Insights

Major companies operating in the eosinophilic asthma market are developing innovative drugs to target specific immune pathways, reduce inflammation, and improve patient outcomes through personalized treatment options. A monoclonal antibody is a type of laboratory-made molecule that can mimic the immune system's ability to fight off harmful pathogens such as viruses and bacteria that are created through a process involving the fusion of a specific antibody-producing cell with a cancer cell, allowing the production of large quantities of identical antibodies. For instance, in August 2024, AstraZeneca plc, a UK-based biopharmaceutical company, announced Fasenra was approved by China's National Medical Products Association, a China-based government agency, for the treatment of severe eosinophilic asthma. It is specifically indicated for patients with severe eosinophilic asthma, a condition characterized by high levels of eosinophils, which can lead to inflammation and worsening asthma symptoms. It is a monoclonal antibody that targets and depletes eosinophils through a unique mechanism. Fasenra enhances the immune system's ability by binding to the IL-5 receptor on eosinophils to reduce eosinophil levels in the blood and tissues. The dosing regimen involves an initial loading phase followed by maintenance doses. Patients usually receive injections every four weeks for the first three doses, followed by every eight weeks thereafter.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Eosinophilic Asthma Market?

In February 2024, GSK plc, a UK-based biopharmaceutical company, acquired Aiolos Bio for $1 billion. With this acquisition, GSK aims to boost its respiratory portfolio by targeting severe asthma patients with low T2 inflammation and expand its market reach and leadership in respiratory therapies while addressing a broader spectrum of asthma patients. Aiolos Bio is a US-based biotechnology company that specializes in developing treatments for respiratory and inflammatory conditions, including eosinophilic asthma.

Regional Outlook

North America was the largest region in the eosinophilic asthma market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Eosinophilic Asthma Market?

The eosinophilic asthma market consists of sales of mepolizuma and benralizumab. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Eosinophilic Asthma Market Report 2026?

The eosinophilic asthma market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the eosinophilic asthma industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Eosinophilic Asthma Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $3.71 billion
Revenue Forecast In 2035 $6.92 billion
Growth Rate CAGR of 17.4% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Disease, Treatment, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Roche Holding AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, GSK plc, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Regeneron Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A., Pfizer Inc., Merck & Co. Inc., Johnson & Johnson, Bayer AG, Eli Lilly and Company, AbbVie Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Cipla Ltd., Sumitomo Dainippon Pharma Co. Ltd., Kyowa Kirin Co. Ltd., UCB S.A., 4D Pharma plc, MorphoSys AG, Avalo Therapeutics Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Eosinophilic Asthma Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Eosinophilic Asthma Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Eosinophilic Asthma Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Eosinophilic Asthma Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Growing Adoption Of Biologic Therapies

4.2.2 Increased Focus On Severe Asthma Phenotypes

4.2.3 Rising Demand For Targeted Immunotherapy

4.2.4 Expansion Of Specialized Respiratory Clinics

4.2.5 Emphasis On Reducing Exacerbation Rates

5. Eosinophilic Asthma Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Pulmonology Centers

5.4 Research Hospitals

5.5 Home Healthcare Providers

6. Eosinophilic Asthma Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Eosinophilic Asthma Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Eosinophilic Asthma PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Eosinophilic Asthma Market Size, Comparisons And Growth Rate Analysis

7.3. Global Eosinophilic Asthma Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Eosinophilic Asthma Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Eosinophilic Asthma Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Eosinophilic Asthma Market Segmentation

9.1. Global Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Severe Eosinophilic Asthma, Mild To Moderate Eosinophilic Asthma

9.2. Global Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Biologics, Bronchodilators, Corticosteroids, Immunomodulators, Other Treatments

9.3. Global Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Other End Users

9.4. Global Eosinophilic Asthma Market, Sub-Segmentation Of Severe Eosinophilic Asthma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Refractory Eosinophilic Asthma, Late-Onset Eosinophilic Asthma

9.5. Global Eosinophilic Asthma Market, Sub-Segmentation Of Mild To Moderate Eosinophilic Asthma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Early-Onset Eosinophilic Asthma, Intermittent Eosinophilic Asthma

10. Eosinophilic Asthma Market Regional And Country Analysis

10.1. Global Eosinophilic Asthma Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Eosinophilic Asthma Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Eosinophilic Asthma Market

11.1. Asia-Pacific Eosinophilic Asthma Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Eosinophilic Asthma Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Eosinophilic Asthma Market

12.1. China Eosinophilic Asthma Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Eosinophilic Asthma Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Eosinophilic Asthma Market

13.1. India Eosinophilic Asthma Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Eosinophilic Asthma Market

14.1. Japan Eosinophilic Asthma Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Eosinophilic Asthma Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Eosinophilic Asthma Market

15.1. Australia Eosinophilic Asthma Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Eosinophilic Asthma Market

16.1. Indonesia Eosinophilic Asthma Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Eosinophilic Asthma Market

17.1. South Korea Eosinophilic Asthma Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Eosinophilic Asthma Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Eosinophilic Asthma Market

18.1. Taiwan Eosinophilic Asthma Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Eosinophilic Asthma Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Eosinophilic Asthma Market

19.1. South East Asia Eosinophilic Asthma Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Eosinophilic Asthma Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Eosinophilic Asthma Market

20.1. Western Europe Eosinophilic Asthma Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Eosinophilic Asthma Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Eosinophilic Asthma Market

21.1. UK Eosinophilic Asthma Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Eosinophilic Asthma Market

22.1. Germany Eosinophilic Asthma Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Eosinophilic Asthma Market

23.1. France Eosinophilic Asthma Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Eosinophilic Asthma Market

24.1. Italy Eosinophilic Asthma Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Eosinophilic Asthma Market

25.1. Spain Eosinophilic Asthma Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Eosinophilic Asthma Market

26.1. Eastern Europe Eosinophilic Asthma Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Eosinophilic Asthma Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Eosinophilic Asthma Market

27.1. Russia Eosinophilic Asthma Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Eosinophilic Asthma Market

28.1. North America Eosinophilic Asthma Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Eosinophilic Asthma Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Eosinophilic Asthma Market

29.1. USA Eosinophilic Asthma Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Eosinophilic Asthma Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Eosinophilic Asthma Market

30.1. Canada Eosinophilic Asthma Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Eosinophilic Asthma Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Eosinophilic Asthma Market

31.1. South America Eosinophilic Asthma Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Eosinophilic Asthma Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Eosinophilic Asthma Market

32.1. Brazil Eosinophilic Asthma Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Eosinophilic Asthma Market

33.1. Middle East Eosinophilic Asthma Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Eosinophilic Asthma Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Eosinophilic Asthma Market

34.1. Africa Eosinophilic Asthma Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Eosinophilic Asthma Market, Segmentation By Disease, Segmentation By Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Eosinophilic Asthma Market Regulatory and Investment Landscape

36. Eosinophilic Asthma Market Competitive Landscape And Company Profiles

36.1. Eosinophilic Asthma Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Eosinophilic Asthma Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Eosinophilic Asthma Market Company Profiles

36.3.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. Eosinophilic Asthma Market Other Major And Innovative Companies

GSK plc, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Regeneron Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A., Pfizer Inc., Merck & Co. Inc., Johnson & Johnson, Bayer AG, Eli Lilly and Company, AbbVie Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited

38. Global Eosinophilic Asthma Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Eosinophilic Asthma Market

40. Eosinophilic Asthma Market High Potential Countries, Segments and Strategies

40.1 Eosinophilic Asthma Market In 2030 - Countries Offering Most New Opportunities

40.2 Eosinophilic Asthma Market In 2030 - Segments Offering Most New Opportunities

40.3 Eosinophilic Asthma Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Eosinophilic Asthma Market, Overview Of Key Products - Product Examples
  • Table 2: Global Eosinophilic Asthma Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Eosinophilic Asthma Market, Supply Chain Analysis
  • Table 4: Global Eosinophilic Asthma Market, Major Raw Material Providers
  • Table 5: Global Eosinophilic Asthma Market, Major Resource Providers
  • Table 6: Global Eosinophilic Asthma Market, Major Manufacturers (Suppliers)
  • Table 7: Global Eosinophilic Asthma Market, Major Distributors And Channel Partners
  • Table 8: Global Eosinophilic Asthma Market, Key Technologies & Future Trends
  • Table 9: Global Eosinophilic Asthma Market, Major Trends
  • Table 10: Global Eosinophilic Asthma Market, Major End Users
  • Table 11: Global Eosinophilic Asthma Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Eosinophilic Asthma Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Eosinophilic Asthma Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Eosinophilic Asthma Market - TAM, US$ Billion, 2025
  • Table 15: Global Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Eosinophilic Asthma Market, Sub-Segmentation Of Severe Eosinophilic Asthma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Eosinophilic Asthma Market, Sub-Segmentation Of Mild To Moderate Eosinophilic Asthma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Eosinophilic Asthma Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Eosinophilic Asthma Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Global Eosinophilic Asthma Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 95: Global Eosinophilic Asthma Market - Company Scoring Matrix
  • Table 96: Roche Holding AG Financial Performance
  • Table 97: Sanofi S.A. Financial Performance
  • Table 98: Bristol-Myers Squibb Company Financial Performance
  • Table 99: AstraZeneca plc Financial Performance
  • Table 100: Novartis AG Financial Performance
  • Table 101: Global Eosinophilic Asthma Market, Competitive Benchmarking (In USD Billions)
  • Table 102: Global Eosinophilic Asthma Market, Competitive Dashboard
  • Table 103: Global Eosinophilic Asthma Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 104: Global, Eosinophilic Asthma Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030
  • Table 105: Global, Eosinophilic Asthma Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Table 106: Global, Eosinophilic Asthma Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

    Figure 1: Global Eosinophilic Asthma Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Eosinophilic Asthma Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Eosinophilic Asthma Market, Supply Chain Analysis
  • Figure 4: Global Eosinophilic Asthma Market, Major Raw Material Providers
  • Figure 5: Global Eosinophilic Asthma Market, Major Resource Providers
  • Figure 6: Global Eosinophilic Asthma Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Eosinophilic Asthma Market, Major Distributors And Channel Partners
  • Figure 8: Global Eosinophilic Asthma Market, Key Technologies & Future Trends
  • Figure 9: Global Eosinophilic Asthma Market, Major Trends
  • Figure 10: Global Eosinophilic Asthma Market, Major End Users
  • Figure 11: Global Eosinophilic Asthma Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Eosinophilic Asthma Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Eosinophilic Asthma Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Eosinophilic Asthma Market - TAM, US$ Billion, 2025
  • Figure 15: Global Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Eosinophilic Asthma Market, Sub-Segmentation Of Severe Eosinophilic Asthma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Eosinophilic Asthma Market, Sub-Segmentation Of Mild To Moderate Eosinophilic Asthma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Eosinophilic Asthma Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Eosinophilic Asthma Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, Eosinophilic Asthma Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Eosinophilic Asthma Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Eosinophilic Asthma Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Global Eosinophilic Asthma Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 95: Global Eosinophilic Asthma Market - Company Scoring Matrix
  • Figure 96: Roche Holding AG Financial Performance
  • Figure 97: Sanofi S.A. Financial Performance
  • Figure 98: Bristol-Myers Squibb Company Financial Performance
  • Figure 99: AstraZeneca plc Financial Performance
  • Figure 100: Novartis AG Financial Performance
  • Figure 101: Global Eosinophilic Asthma Market, Competitive Benchmarking (In USD Billions)
  • Figure 102: Global Eosinophilic Asthma Market, Competitive Dashboard
  • Figure 103: Global Eosinophilic Asthma Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 104: Global, Eosinophilic Asthma Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030
  • Figure 105: Global, Eosinophilic Asthma Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Figure 106: Global, Eosinophilic Asthma Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Allergic Rhinitis Market Report 2026 - Global Outlook – By Type (Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis), By Treatment (Antihistamines, Corticosteroids, Immunotherapy, Dec...

Corticosteroids Market Report 2026 - Global Outlook – By Product (Glucocorticoids, Mineralocorticoids), By Application (Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applicati...

Asthma Spacers Market Report 2026 - Global Outlook – By Product (Aerochamber, Optichamber, Volumatic, Inspirease, Other Products), By Distribution Channels (E-commerce Channels, Retail Pharmacies, Hospital Pharmacies, Ot...

Allergic Rhinitis Drugs Market Report 2026 - Global Outlook – By Disease (Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis), By Treatment (Antihistamines, Immunotherapy, Corticoster...

Intelligent Asthma Monitoring Devices Market Report 2026 - Global Outlook – By Product (Wearable Asthma Monitoring Devices, Smart Inhalers), By Distribution Channel (Retail Pharmacies, Online Pharmacies), By End User (Ho...

Asthma Drugs Market Report 2026 - Global Outlook – By Type Of Asthma (Allergic, Non-Allergic), By Asthma Trigger Type (Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational A...

Anti-Asthmatic And COPD Drugs Market 2021 - By Drug Class (Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs), By End User (Asthma Patients, COPD Patients), By Distribution Channel (Gener...

Anti-Asthmatic And COPD Drugs Market 2021 - By Drug Class (Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs), By End User (Asthma Patients, COPD Patients), By Distribution Channel (Gener...

Frequently Asked Questions

The Eosinophilic Asthma market was valued at $3.16 billion in 2025, increased to $3.71 billion in 2026, and is projected to reach $6.92 billion by 2030.

The global Eosinophilic Asthma market is expected to grow at a CAGR of 16.9% from 2026 to 2035 to reach $6.92 billion by 2035.

Some Key Players in the Eosinophilic Asthma market Include, Roche Holding AG, Sanofi S.A., Bristol‑Myers Squibb Company, AstraZeneca plc, Novartis AG, GSK plc, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Regeneron Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A., Pfizer Inc., Merck & Co. Inc., Johnson & Johnson, Bayer AG, Eli Lilly and Company, AbbVie Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Cipla Ltd., Sumitomo Dainippon Pharma Co. Ltd., Kyowa Kirin Co. Ltd., UCB S.A., 4D Pharma plc, MorphoSys AG, Avalo Therapeutics Inc. .

Major trend in this market includes: Advancements In Targeted Therapies For Severe Asthma Management. For further insights on this market. request a sample here

North America was the largest region in the eosinophilic asthma market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the eosinophilic asthma market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us